To assess the costs of the Smoking Cessation Program in the Brazilian Unified Health System and estimate the cost of its full implementation in a Brazilian municipality.
INTRODUCTION
Smoking is an epidemic disease arising from nicotine addiction and is the leading cause of preventable deaths in the world, estimated in 6 million annually a . It is estimated that it will be responsible for more 175 The economic burden of smoking to society is also significant. The annual expenses with treatment of tobacco-related diseases and the loss of productivity resulting from the morbidity and mortality of smoking have generated an economic burden of U$193 billion in the United States between 2000-2004 1 and of €21 billion in Germany, in 2003 13 .
In Brazil, smoking resulted in 130,000 deaths in 2008, 13 .0% of total deaths, already surpassing international estimates of 10.0% of deaths attributable to tobacco in 2015. The costs of treating tobacco-related diseases amounted to R$21 billion in 2011, considering the public and supplemental health systems 11,c .
Since the 1980s, the Brazilian Ministry of Health has been adopting various actions for smoking control, which culminated in the creation of the National Smoking Control Program, coordinated by the National Cancer Institute (INCA) since the early 1990s d , and today part of the National Smoking Control Policy, which has an intersectoral nature. The program encompasses from comprehensive actions, as promoting smoke-free environments, to more focused ones, as promotion and support for smoking cessation. Focusing on the latter, the Smoking Cessation Program was implemented in the Brazilian Unified Health System (SUS) in 2002, to increase the access of smokers to effective methods for smoking cessation, and adopting the methods recognized as first line treatment In the treatment model adopted by Brazil, after initial assessment appointment, smokers receive intensive cognitive-behavioral therapy, which combines cognitive interventions with training of behavioral skills 10 . The therapy is performed in a group from 10 to 15 smokers or individually, being composed of four structured initial sessions of 90 minutes, preferably weekly, followed by 12 sessions, until the completion of one year of treatment. Pharmacotherapy, when indicated, is made by nicotine replacement therapy (NRT), with the use of transdermal nicotine patches (21, 14 , and 7 mg), nicotine gum or lozenge (2 and 4 mg), and the antidepressant bupropion hydrochloride (150 mg), used individually or in combination. The program also includes brief counseling, conducted during the routine consultations, lasting from three to five minutes
The program is managed articulately by the federal, state, and municipal levels of SUS management. The trainings, technical support to activities, and distribution of used inputs are done "cascading", from the federal to the municipal level. Educational materials and medicines are supplied by the Ministry of Health, and may be supplemented by the states and municipalities. The information is collected and consolidated from the local to the central level.
The effectiveness of brief counseling, intensive group therapy, NRT, and bupropion was evidenced by several meta-analyses 3, 23, 26 . The combination of behavioral therapy with the use of medicines is recommended, showing slightly better results when the behavioral therapy is more intensive 24, 25 . In Brazil, cessation rates were reported between 23.5% and 50.8%, after at least six months from the beginning of treatment 14, 20, 21 .
In view of the scarcity of resources for health, as well as of effectiveness, we must also consider the costs of health programs. These are still an essential part of health economic evaluations that compare treatment alternatives, producing information on the costs and benefits of them, thus orienting the decision-making 7 . 8 , and U$183 (telephone counseling, pharmacotherapy, and promotion and advertising) 18 . In Brazil, there are no studies so far that assess the cost of the program implemented on SUS.
The cost estimate of the Smoking Cessation Program in Brazil is, therefore, an important subsidy to support SUS managers in planning actions and maximizing the use of resources, as well as in decision-making regarding their prioritization, guiding the efficient allocation of resources.
The aim of this study was to estimate the costs of the program in a Brazilian municipality, including the treatment of the smoker and program management, considering the different levels of management involved. We also estimated costs if the service was expanded to fully meet the demand of the municipality's smokers motivated to quit.
METHODS
Cost study of the Smoking Cessation Program, implemented in primary health care. The unit of analysis was the municipality of Goiania, adopting the year of 2010 as time frame, both for measurement of data and valuation of inputs. We considered the perspective of SUS, funder of the program in the public health sector in Brazil, including direct medical and non-medical costs and management costs. Indirect costs were not considered.
The activities were identified and grouped into components of the two program axes: behavioral therapy and treatment of smoking and management. The behavioral therapy and treatment axis comprises the following components: (i) consultations (medical and nursing), including initial clinical evaluation and return visits; (ii) intensive cognitivebehavioral therapy sessions, including their preparation and execution; and (iii) phamacotherapy. In Goiania, the group sessions are conducted over six months. The brief counseling was not considered. The management axis includes two components: (i) technical support and (ii) training.
The costs of behavioral therapy and treatment of smoking were estimated considering a convenience sample of health facilities and extrapolated to the municipality as a whole, also using data available to all groups and patients attended. The sample was selected considering the following criteria: (i) systematization and availability of information; (ii) time of implementation of the program; (iii) quantity of groups; (iv) type of health facility; and (v) location. Six facilities were selected, considering different types and locations, with the largest number of groups, deployment time, and better quality of information. The program management costs were was estimated considering the activities carried out by municipal, state, and federal coordinations of the program.
The activities of the two axes of the program were estimated by micro-costing, measuring the amount used of each resource and assigning it the corresponding unit value. The resources used were identified as cost items and categorized as medical and non-medical costs, considering recurrent and capital costs. The cost structure, according to the components and axes of the program, is presented in Table 1 . We included the costs incurred by the three levels of SUS management.
Shared costs with other health programs and actions were assigned to the Smoking Cessation Program using as an indicator of the attributable fraction the proportion of professionals' time dedicated to the program in relation to the total time of the goal activities of the health unit or, in the case of management, of the administrative sector where the coordination of the program is.
In the sampled health facilities, the costing of the behavioral therapy and treatment was made by therapeutic group, according to the specific care configuration adopted in the facility regarding the frequency and duration of activities and professionals involved. The data were obtained in interviews with the coordinators of the groups. The professionals' time dedicated to the cognitive-behavioral therapy sessions was obtained in individual interviews, considering the average time for the cost estimate. The time of the consultations and of the dispensation of medicines was arbitrated considering the literature 22,g To estimate the cost of the behavioral therapy and treatment in the municipality as a whole, we considered that all smokers attended in 2010 (n = 803) underwent a common configuration of care. The parameters used in the base scenario of costs estimate of each component of behavioral and treatment and the respective data source are presented in Table 2 .
The cost with human resources was obtained by multiplying the frequency of the activity by the number of professionals involved, by the time of duration, and by the average remuneration of professionals, plus employers' charges. The remaining medical costs were added to the value obtained (cost with clinic equipment for consultations and cost with NRT and antidepressants for medicine treatment). Non-medical costs were estimated based on the percentage they represented in relation to medical costs in the sampled health facilities. The sum of medical and non-medical costs was multiplied by the number of patients seen, for consultations and pharmacotherapy, and by the number of groups (n = 44), for sessions. In the consultations, patients receiving or not medicines were stratified, considering that patients present at the fourth session of cognitive-behavioral therapy made return visits. The sum of the total cost with consultations, sessions of behavioral therapy, and pharmacotherapy resulted in the total cost of the therapy and treatment of smoking.
Management costs were estimated for each realm of management. The data were obtained with the program coordinators, in administrative records and management information systems of the three realms. The fraction of federal and state cost attributable to the municipality of Goiania was obtained based on the number of cities managed by these coordinations. The total of management assigned to the municipality was divided between the groups conducted.
The Figure shows the analysis of the cost estimate, considering the distribution of all patients seen by the components of the intensive behavioral therapy and treatment of smoking (A) and the final cost estimate of the Smoking Cessation Program, including management (B). The results are presented as total cost of the program, per group, stratified by cost item, component, and funding source. Cost per patient was estimated by dividing the cost of the program among all patients attended at the first session of cognitive-behavioral therapy. The cost per patient that quit smoking corresponds to the total cost divided by the patients who were not smoking at the end of the treatment.
The expansion of the program to meet the demand of all smokers motivated to quit smoking in the municipality was set as full implementation. For the estimation of the number of smokers to be attended, we considered the prevalence of smokers in the population with 15 years or more of age (17.0%) i,j , the percentage of those trying to quit smoking (41.8%) i,j , discounting the natural cessation rate, i.e., those who would stop smoking without treatment (2.5%) 5 , and individuals previously attended in 2010 (803). We considered the smokers who were potential users of SUS for the treatment (50.0%)
The smokers were distributed by the three components of the behavioral therapy and treatment, according to common care configuration of the municipality, considering maximum efficiency: all primary care facilities conducting two groups of 15 smokers per year, with provision of medicines to 84.0% of them, according to the degree of dependence to nicotine of the 2010 patients, measured by Fagerström test. The cost of management was estimated by multiplying the annual cost of 2010 by the number of years required for all smokers to access treatment.
A sensitivity analysis was performed to assess the impact of the variation of parameters on the results of the behavioral therapy and treatment costs. Many parameters not known or with different values on different sources of information were analyzed. In addition to the base scenario, three new scenarios were created: (i) SMS-Goiania Guidance -considering recommendations or administrative records of the municipal coordination of the program; (ii-iii) Minimum and Maximum, considering respectively minimum and maximum values found in the sampled units and data sources ( 
RESULTS
In the sampled health facilities, the cost of the behavioral therapy and treatment per therapeutic group, composed of eight to 36 smokers, ranged from R$2,937 to R$9,864. From this total, medical costs accounted for, in average, 85.8% and human resources costs, 73.1% (ranging from 62.3% to 90.2%). Including management costs, the total cost of the Smoking Cessation Program per group ranged between R$5,130 and R$12,057. The greater participation in the funding of the program came from the municipality, responsible for 78.2% of the total cost, followed by the federal (13.6%) and state level (8.4%). The largest federal participation was related to medication, and the Ministry of Health was responsible for 67.7% of the total cost with NRT and bupropion.
In the municipality as a whole, 44 groups of six to 55 smokers were conducted, generating a total program cost of R$429,079 in the base scenario, with 78.0% regarding the behavioral therapy and treatment for smoking cessation. The component of greater participation in the costs of the behavioral therapy and treatment were of cognitive-behavioral therapy sessions (54.0%), followed by pharmacotherapy (24.3%), and consultations (21.7%). The average cost per patient was R$ 534, and, per quitter, R$1,435. The average cost of pharmacotherapy per patient who used NRT or bupropion was R$174. In the sensitivity analysis, the results varied in the minimum and maximum scenarios, but not in the SMS-Goiania Guidance scenario ( Table 4 ).
The full implementation of the program would require R$20.28 million, benefiting 35,323 smokers motivated to quit smoking, out of a total of 175,331 smokers, representing R$574 per patient. From this total, the behavioral therapy and treatment cost would be R$19.05 million, and the management cost, R$1.24 million. In the sensitivity analysis, the total cost ranged between R$13.61 and R$34.35 million
DISCUSSION
This study contributes to the knowledge of the costs of the Smoking Cessation Program in Brazil, estimating the costs not only of treatment, but also of the program management in the three management levels, with cost per patient that quit smoking close to the smaller ones referred to in the international literature.
The comparison of the results with the literature is difficult, given the methodological variations concerning the considered perspective of analysis, assumptions, costing method, and cost items 19 . There is also diversity in the format of programs evaluated in different countries, complicating the external validity of the results from different studies. Estimates of cost per quitter in programs with behavioral therapy generally less intensive than in Brazil, not including management, ranged between U$1,353 and U$3,596 2, 6, 27 . In Minnesota, USA, the cost per participant and per quitter was U$352 and U$1,934, respectively, including NRT, bupropion, minimal approach, and telephone counseling sessions 2 . In Switzerland, these costs were of U$1,182 and U$1,353, respectively, including NRT and nine counseling sessions 27 . Cost estimate for implementation of the recommendations proposed in guideline of the USA k , in the format that most closely matches the Brazilian program (intensive counseling with seven sessions in group and NRT), was of 2,310 and U$3,596 per quitter, considering nicotine patch and gum, respectively 6 .
The proportion of costs with pharmacotherapy in Goiania (24.3%) was not high, resembling the observed in the program evaluated in Switzerland (22.8%) 27 . The greater participation of the group sessions, responsible for 54.0% of the intervention cost, associated to the proportion of costs with human resources (73.1%), observed among the sampled facilities in this study and similar to that found in the Family Health Program of Porto Alegre in 2002 (65.5%) 4 , indicates the importance of maximizing the use of professionals' time. Such evidence strengthen the relevance of appropriate planning of the actions carried out in the municipality, responsible for 78.0% of the total cost of the program.
The cost with medicines per patient, including NRT and bupropion, which ranged from R$174 to R$194 in the different scenarios, differs from the findings of another national study This study has strengths and limitations. The costing methodology used allowed us to identify resources with a high degree of detail, giving precision to the results, in a comprehensive approach, which also considered the program management. Some limitations arise from the difficulty of estimating the cost and the portion attributable to the program of activities, such as the dissemination and the process of buying medicines. At the federal level, we did not include transportation costs, general expenses, and capital costs. However, as these costs were not influential in the cost of the municipal and state management, we believe that they would not significantly increase the costs at the federal level. Another limitation refers to information about smoking cessation, obtained based on the patients' self-report, without biochemistry confirmation of abstinence.
When estimating the costs of full implementation, we have incurred in uncertainties on various parameters. The number of smokers to be treated may be underestimated, because we considered only the most advanced stage of motivation for treatment, while the previous stage has been mentioned as a predictor of success m . It may also have been overestimated, because the number of smokers who would not need treatment to quit smoking was obtained by the natural cessation rate of the international literature, which can be higher among Brazilian smokers, given the significant decrease in the smoking prevalence experienced by the Country in recent years (35.0% between 1989 and 2003) 12 . We considered that the structure for municipal management available in 2010, higher than in previous years of implementation of the program, would be able to absorb the increased demand for treatment. Despite the cost variation described, interventions for smoking cessation have been considered highly cost-effective 9, 19 . These cost-effectiveness analyses are not transposable to Brazil. However, having in mind that, in general, they consider smoking cessation rates lower than those suggested in national studies, it is possible that the cost-effectiveness of treatment for smoking cessation in the Country is even more favorable.
In Brazil, 82.0% of lung cancer cases, one of the main tobacco-related diseases, are attributable to smoking. Their treatment in specialized public hospital was estimated in R$28,901 in 2006 for patients with a history of smoking, cost significantly higher than the cost per patient that quit smoking in the Smoking Cessation Program 15,c . Another strategy of cancer prevention, the screening of breast cancer in women, considered a priority in recent years, had cumulative cost estimated at R$1,008 for the usual care in SUS, near the cost per patient that quit smoking 17 . The value transferred by the Ministry of Health to the municipality of Goiania in 2010 for conduction of mammograms for screening, R$1.34 million n , excels in three times the total cost of the Smoking Cessation Program. Although the value of transfers does not represent the cost of the intervention, but the federal contribution of resources for their realization (according to unit value set by the Ministry for compensation of the procedure), its magnitude shows the effort made for prevention of breast cancer. Considering that breast cancer resulted in 12,705 deaths in women in 2010 o , it is important to note the potential benefit of treatment of smoking, a risk factor for chronic diseases of great world impact and responsible for 130,000 annual deaths in the Country c,p .
Corroborating the evidence available in the international literature, this study suggests that the Smoking Cessation Program, implemented on SUS about a decade ago, has good performance regarding the cost per patient that quit smoking in Goiania, a municipality that follows the treatment model recommended nationally. This cost can be even smaller with increasing access and demand management, diluting the costs of program management and promoting greater use of the cognitive-behavioral therapy sessions.
In view of the major impact of smoking in the morbidity and mortality of the Brazilian population, the high cost of treating tobacco-related diseases, and the favorable costeffectiveness of interventions for treatment of smoking, the Smoking Cessation Program must be considered a priority when planning the allocation of health resources. The evidence that the total funding of treatment, i.e., without additional cost to the patient, results in higher rates of abstinence reinforces such recommendation 16 .
We suggest the conduction of studies to assess the indication of treatment of smoking for SUS users in clinical practice, assisting in the development of strategies for referencing patients and increasing the scope of the program. Also, studies about the cost-effectiveness of the program are needed to provide more subsidies for the decision-making of managers as to their prioritization and encouragement.
